These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 27709492

  • 1. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
    Yuan B, Fu F, Huang S, Lin C, Yang G, Ma K, Shi H, Yang Z.
    Mol Neurobiol; 2017 Oct; 54(8):6187-6197. PubMed ID: 27709492
    [Abstract] [Full Text] [Related]

  • 2. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL, Chen J, Yang F, Li GQ, Zheng LX, Wu YZ.
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [Abstract] [Full Text] [Related]

  • 3. Programmed death (PD)-1 attenuates macrophage activation and brain inflammation via regulation of fibrinogen-like protein 2 (Fgl-2) after intracerebral hemorrhage in mice.
    Yuan B, Huang S, Gong S, Wang F, Lin L, Su T, Sheng H, Shi H, Ma K, Yang Z.
    Immunol Lett; 2016 Nov; 179():114-121. PubMed ID: 27717876
    [Abstract] [Full Text] [Related]

  • 4. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC, Lu CL, Chen L, Ge K, Yang LL, Li W, Wu YH.
    World J Gastroenterol; 2016 Dec 14; 22(46):10148-10157. PubMed ID: 28028363
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY, Zhang KQ.
    Int Urol Nephrol; 2018 Aug 14; 50(8):1545-1553. PubMed ID: 29594894
    [Abstract] [Full Text] [Related]

  • 6. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K, Li GQ, He QH, Li Y, Tang M, Zheng QY, Xu GL, Zhang KQ.
    Int Immunopharmacol; 2017 Dec 14; 53():17-23. PubMed ID: 29031143
    [Abstract] [Full Text] [Related]

  • 7. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y, Xu SQ, Long WJ, Zhang XY, Lu HL.
    Eur Rev Med Pharmacol Sci; 2018 Nov 14; 22(22):7994-8003. PubMed ID: 30536348
    [Abstract] [Full Text] [Related]

  • 8. Complement C5a-C5aR interaction enhances MAPK signaling pathway activities to mediate renal injury in trichloroethylene sensitized BALB/c mice.
    Zhang JX, Zha WS, Ye LP, Wang F, Wang H, Shen T, Wu CH, Zhu QX.
    J Appl Toxicol; 2016 Feb 14; 36(2):271-84. PubMed ID: 26095957
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
    Li G, Fan RM, Chen JL, Wang CM, Zeng YC, Han C, Jiao S, Xia XP, Chen W, Yao ST.
    Clin Exp Immunol; 2014 Feb 14; 175(2):285-95. PubMed ID: 24117111
    [Abstract] [Full Text] [Related]

  • 10. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer.
    Piao C, Zhang WM, Li TT, Zhang CC, Qiu S, Liu Y, Liu S, Jin M, Jia LX, Song WC, Du J.
    Exp Cell Res; 2018 May 15; 366(2):127-138. PubMed ID: 29551360
    [Abstract] [Full Text] [Related]

  • 11. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC, Yang FC, Lin CH, Hsieh SL, Chen NJ.
    Cell Signal; 2014 Jul 15; 26(7):1409-19. PubMed ID: 24631530
    [Abstract] [Full Text] [Related]

  • 12. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
    Chen J, Sun ZH, Chen LY, Xu F, Zhao YP, Li GQ, Tang M, Li Y, Zheng QY, Wang SF, Yang XH, Wu YZ, Xu GL.
    Aging (Albany NY); 2020 Jul 15; 12(14):14285-14299. PubMed ID: 32669478
    [Abstract] [Full Text] [Related]

  • 13. Role of C5a-C5aR interaction in sepsis.
    Guo RF, Riedemann NC, Ward PA.
    Shock; 2004 Jan 15; 21(1):1-7. PubMed ID: 14676676
    [Abstract] [Full Text] [Related]

  • 14. C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
    Syed SN, Rau E, Ziegelmann M, Sogkas G, Brüne B, Schmidt RE.
    Eur J Immunol; 2018 Apr 15; 48(4):696-704. PubMed ID: 29277896
    [Abstract] [Full Text] [Related]

  • 15. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat.
    Daveau M, Benard M, Scotte M, Schouft MT, Hiron M, Francois A, Salier JP, Fontaine M.
    J Immunol; 2004 Sep 01; 173(5):3418-24. PubMed ID: 15322206
    [Abstract] [Full Text] [Related]

  • 16. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H, Fisher AJ, Mickler EA, Duerson F, Cummings OW, Peters-Golden M, Twigg HL, Woodruff TM, Wilkes DS, Vittal R.
    FASEB J; 2016 Jun 01; 30(6):2336-50. PubMed ID: 26956419
    [Abstract] [Full Text] [Related]

  • 17. Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice.
    Li L, Xiong ZY, Qian ZM, Zhao TZ, Feng H, Hu S, Hu R, Ke Y, Lin J.
    Neurobiol Dis; 2014 Jun 01; 66():74-82. PubMed ID: 24607885
    [Abstract] [Full Text] [Related]

  • 18. Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.
    Sun D, Zhang M, Liu G, Wu H, Zhu X, Zhou H, Shi M.
    Infect Immun; 2016 Jan 01; 84(1):216-29. PubMed ID: 26502909
    [Abstract] [Full Text] [Related]

  • 19. Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease.
    Johswich K, Martin M, Bleich A, Kracht M, Dittrich-Breiholz O, Gessner JE, Suerbaum S, Wende E, Rheinheimer C, Klos A.
    Inflamm Bowel Dis; 2009 Dec 01; 15(12):1812-23. PubMed ID: 19714742
    [Abstract] [Full Text] [Related]

  • 20. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
    De Hoog VC, Timmers L, Van Duijvenvoorde A, De Jager SC, Van Middelaar BJ, Smeets MB, Woodruff TM, Doevendans PA, Pasterkamp G, Hack CE, De Kleijn DP.
    Cardiovasc Res; 2014 Sep 01; 103(4):521-9. PubMed ID: 24935433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.